United States · FDA National Drug Code directory

Carbamazepine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62332-421_e1678991-b726-4e47-bb00-98c9d7277a1d
Product NDC
62332-421
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
Carbamazepine
Labeler
Alembic Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20250726
Source listing expiry
20271231

Source-listed ingredients

  • CARBAMAZEPINE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62332-421-31) · 62332-421-31
  • 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62332-421-91) · 62332-421-91

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →